Surgical Treatment of Irreducible Atlantoaxial Dislocation

A Randomized Controlled Study for Surgical Treatment of Irreducible Atlantoaxial Dislocation

NCT05847270•Peking University Third Hospital

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Irreducible Atlantoaxial Dislocation

Interventions

Anterior and posterior treatment strategy

Simple posterior approach treatment strategy

Locations

China

Locations (1)

Peking University Third Hospital

Beijing, Beijing Municipality, China

Key Dates

Start Date

July 11, 2023

Primary Completion Date

December 31, 2025

Completion Date

December 31, 2026

Last Updated

January 8, 2024

Contacts

Shenglin Wang, MD

CONTACT

+86 13501380281 pkuwsl@126.com

Shilin Xue, MD

CONTACT

+86 18518982712 shilinx_pku@163.com

Sponsors

Lead Sponsor

Peking University Third Hospital

Collaborators

Xuanwu Hospital, Beijing
Second Affiliated Hospital, School of Medicine, Zhejiang University
Second Affiliated Hospital of Wenzhou Medical University
Tianjin People's Hospital
First Affiliated Hospital of Kunming Medical University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 8, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions